Skip to main content
. 2017 Mar 3;8(17):28042–28051. doi: 10.18632/oncotarget.15886

Figure 1. The cell growth inhibition of the Ishikawa cells and Ishikawa-PR cells with a time- and dose-increase manner.

Figure 1